FR2944793B1 - Derives de monosaccharides et leur utilisation pour reguler l'homeostasie cutanee - Google Patents

Derives de monosaccharides et leur utilisation pour reguler l'homeostasie cutanee

Info

Publication number
FR2944793B1
FR2944793B1 FR0952672A FR0952672A FR2944793B1 FR 2944793 B1 FR2944793 B1 FR 2944793B1 FR 0952672 A FR0952672 A FR 0952672A FR 0952672 A FR0952672 A FR 0952672A FR 2944793 B1 FR2944793 B1 FR 2944793B1
Authority
FR
France
Prior art keywords
derivatives
composition
monosaccharides
present
regulating skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0952672A
Other languages
English (en)
Other versions
FR2944793A1 (fr
Inventor
Csiba Maria Dalko
Julien Demaude
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0952672A priority Critical patent/FR2944793B1/fr
Publication of FR2944793A1 publication Critical patent/FR2944793A1/fr
Application granted granted Critical
Publication of FR2944793B1 publication Critical patent/FR2944793B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Abstract

La présente invention se rapporte à l'utilisation de dérivés C-glycosides dans une composition, en particulier cosmétique ou pharmaceutique, le dérivé ou la composition étant destiné à stimuler l'homéostasie épidermique, en particulier pour diminuer les signes du vieillissement de la peau et de ses annexes et/ou du cuir chevelu. La présente invention se rapporte également à un procédé de traitement cosmétique utilisant une telle composition cosmétique. La présente invention concerne enfin de nouveaux dérivés C-glycosides ainsi qu'une composition incluant au moins un de ces dérivés.
FR0952672A 2009-04-23 2009-04-23 Derives de monosaccharides et leur utilisation pour reguler l'homeostasie cutanee Expired - Fee Related FR2944793B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0952672A FR2944793B1 (fr) 2009-04-23 2009-04-23 Derives de monosaccharides et leur utilisation pour reguler l'homeostasie cutanee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0952672A FR2944793B1 (fr) 2009-04-23 2009-04-23 Derives de monosaccharides et leur utilisation pour reguler l'homeostasie cutanee

Publications (2)

Publication Number Publication Date
FR2944793A1 FR2944793A1 (fr) 2010-10-29
FR2944793B1 true FR2944793B1 (fr) 2013-01-18

Family

ID=41559643

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0952672A Expired - Fee Related FR2944793B1 (fr) 2009-04-23 2009-04-23 Derives de monosaccharides et leur utilisation pour reguler l'homeostasie cutanee

Country Status (1)

Country Link
FR (1) FR2944793B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113773291B (zh) * 2021-10-09 2023-04-25 上海昕凯医药科技有限公司 化妆品有效成分玻色因的改进合成方法
CN114835666A (zh) * 2022-06-30 2022-08-02 天津泰普制药有限公司 一种羟丙基四氢吡喃三醇的连续合成方法
CN117229247A (zh) * 2022-10-27 2023-12-15 山东梅奥华卫科技有限公司 一种高活性玻色因的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
FR2818646B1 (fr) * 2000-12-22 2006-06-23 Oreal Nouveaux derives c-glycoside et utilisation
FR2886297B1 (fr) * 2005-05-30 2007-11-23 Oreal Composes c-glycosides et leur utilisation pur depigmenter la peau
FR2899467B1 (fr) * 2006-04-07 2008-05-30 Oreal Utilisation de derive c-glycosides comme agent protecteur et/ou activateur des lymphocytes gamma delta t

Also Published As

Publication number Publication date
FR2944793A1 (fr) 2010-10-29

Similar Documents

Publication Publication Date Title
WO2009032773A3 (fr) Compositions et procédés pour le traitement d'infestations par demodex
MA31167B1 (fr) Inhibiteurs de l'activite de akt
WO2007113851A3 (fr) Nouvelles compositions pour des troubles capillaires et procédé de préparation de celles-ci
WO2008130320A3 (fr) Nouveaux composés 806
WO2011019468A3 (fr) Composition topique ayant un effet éclaircissant sur la peau
DE602007008524D1 (de) Spiroimidazol-derivate als ppar-modulatoren
BRPI0506751B8 (pt) método para isolar uma fração bioativa derivada de suco celular de uma planta de camellia sinensis
WO2009153496A3 (fr) Composes agonistes ppar, preparation et utilisations pour le traitement du diabete et/ou des dyslipidemies
WO2007046097A3 (fr) Compositions topiques pour le traitement ou la prevention de l'irritation cutanee provoquee par l'epilation
WO2006093547A3 (fr) Nouveaux inhibiteurs de la lipoxygénase
WO2008107092A3 (fr) Utilisation de dérivés d'acide 4-hydroxyphénoxy acétique
WO2006117465A3 (fr) Utilisation de polyphenols de cacao pour reguler la pigmentation de la peau
WO2015031971A8 (fr) Composition comprenant un extrait de guaçatonga et un extrait d'aroeira, son utilisation, et méthode de prévention et/ou de traitement des signes provoqués par le viellissement cutané
NO20064951L (no) 1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse
MY144132A (en) Polymorph forms of (2s)-(4e)-n-methyl-5-[3-(5-isoproproxypyridin)yl]-4-penten-2-amine
FR2940972B1 (fr) Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
FR2939135B1 (fr) Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
MA35895B1 (fr) Inhibiteurs d'iap
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
ZA200701798B (en) Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors
FR2952820B1 (fr) Procede de traitement cosmetique
FR2940053B1 (fr) Utilisation de l'acide anisique et/ou d'au moins un de ses derives comme agent antioxydant
FR2944793B1 (fr) Derives de monosaccharides et leur utilisation pour reguler l'homeostasie cutanee
FR3003758B1 (fr) Utilisation cosmetique ou dermatologique d'un extrait de polygonum bistorta
BRPI0916507A2 (pt) compostos, composição cosmética ou farmacêutica, processo de tratamento cosmético não terapêutico da pele e usos não terapêuticos de uma composição cosmética

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20211205